Detail Are Generics Really the Same as Branded Drugs?   Oleh:  Eban, Katherine Jenis: Article from Bulletin/Magazine Dalam koleksi: Fortune vol. 167 no. 1 (Jan. 2013), page 55-57. Topik: Consumers; Generic Drugs; Food and Drug Administration; Bioequivalent Ketersediaan Perpustakaan Pusat (Semanggi) Nomor Panggil: FF16.48 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada     Lihat Detail Induk Isi artikel Consumers are told that generics are just like their name-brand counterparts. More medical professionals are starting to say that's not the case. In October the Food and Drug Administration took a highly unusual step: It declared that a generic drug it had previously approved -- a version of the popular antidepressant Wellbutrin -- was not in fact "bioequivalent" to the name-brand version. The FDA withdrew its approval. The federal action shook the business. Teva Pharmaceuticals (TEVA), which marketed the generic in question, has stopped selling it, and other companies are now testing their versions of Wellbutrin at the FDA's request. The episode is bringing momentum to a movement that has been quietly building among many doctors and medical societies that are increasingly willing to ask a question that borders on heresy: Are generics really identical to the branded products they are meant to replicate? To a surprising degree, they say, the answer is no. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved